Immix Biopharma Inc.

IMMX | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.20

-$0.77 (-9.66%)

At close: Nov 4, 2026, 4:00 PM ET

$7.27

+$0.07 (+0.97%)

After-hours: Nov 5, 2026, 4:27 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-29.44M	-21.7M	-15.6M	-8.23M	-24.38M	-1.15M
Depreciation & Amortization	364.5K	115.39K	5.47K	2.14K	2.47K	2.32K
Stock-Based Compensation	2.44M	3.02M	2.57M	624.07K	218.98K	n/a
Other Working Capital	-384.74K	537.2K	111.84K	-700.15K	-382.64K	111.18K
Other Non-Cash Items	n/a	n/a	n/a	n/a	22.96M	575K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.7M	3.97M	1.65M	195.21K	-391.04K	165.85K
Operating Cash Flow	-23.93M	-14.6M	-11.37M	-7.41M	-1.59M	-404.69K
Capital Expenditures	-732.93K	-1.18M	-52.09K	3	-802	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-6.48M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-7.21M	-1.18M	-52.09K	n/a	-802	n/a
Debt Repayment	n/a	n/a	n/a	-50K	200K	n/a
Common Stock Repurchased	n/a	n/a	n/a	-99.96K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-232K	-6.72K	n/a	n/a
Financial Cash Flow	107.39M	15.95M	15.46M	3.23M	18.85M	n/a
Net Cash Flow	76.25M	172.16K	4.07M	-4.21M	17.25M	-342.93K
Free Cash Flow	-24.66M	-15.77M	-11.42M	-7.41M	-1.59M	-404.69K
Adj. Free Cash Flow	-27.11M	-18.79M	-13.99M	-8.03M	-1.81M	-404.69K
Maintenance CapEx	-364.5K	-115.39K	-5.47K	-3	-802	n/a
Growth CapEx	-368.42K	-1.06M	-46.62K	6	n/a	n/a
Owner Earnings	-24.29M	-14.71M	-11.38M	-7.41M	-1.59M	-404.69K